Clinical Trial Update: Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion of a Phase 1/2 study evaluating IL13-PE38QQR as a pre-operative therapy in patients with recurrent or progressive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme
• Malignant Glioma
• Mixed Oligoastrocytoma

Drugs mentioned

• IL13-PE38QQR

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Malignant Glioma, Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED